Apolipoprotein B, residual cardiovascular risk after acute coronary syndrome, and effects of alirocumab
author
Hagström, Emil
Steg, P. Gabriel
Szarek, Michael
Bhatt, Deepak L.
Bittner, Vera A.
Danchin, Nicolas
Diaz, Rafael
Goodman, Shaun G.
Harrington, Robert A.
Jukema, J. Wouter
Liberopoulos, Evangelos
Marx, Nikolaus
Viigimaa, Margus
statement of authorship
Emil Hagström, P. Gabriel Steg, Michael Szarek, Deepak L. Bhatt, Vera A. Bittner, Nicolas Danchin, Rafael Diaz, Shaun G. Goodman, Robert A. Harrington, J. Wouter Jukema, Evangelos Liberopoulos, Nikolaus Marx, [...], Margus Viigimaa
source
Circulation
publisher
Lippincott Williams and Wilkins
journal volume number month
vol. 146, 9
year of publication
2022
pages
p. 657 - 672
url
https://doi.org/10.1161/CIRCULATIONAHA.121.057807
subject term
koroonahaigus
valgud
kolesterool
kardiovaskulaarne risk
inhibiitorid
keyword
acute coronary syndrome
apolipoproteins B
cholesterol, LDL
heart disease risk factors
PCSK9 inhibitors
ISSN
0009-7322
notes
Bibliogr.: 41 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
1.1
Scopus
Journal metrics at Scopus
Article at Scopus
WOS
Journal metrics at WOS
Article at WOS
category (general)
Medicine
en
Meditsiin
et
category (sub)
Medicine. Cardiology and cardiovascular medicine
en
Meditsiin. Kardioloogia ja kardiovaskulaarmeditsiin
et
Medicine. Physiology (medical)
en
Meditsiin. Füsioloogia (meditsiiniline)
et
kvartiil
Q1
TTÜ department
tervisetehnoloogiate instituut
language
inglise
Uurimisrühm
Research group on diagnostics and treatment technologies of hypertension and atherosclerosis